Skip to main content



Local Cdiff information for Arkansas

Arkansas

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Arkansas.



Local Cdiff information for Arkansas

Arkansas

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Arkansas.

Providers


Regulation


C. diff Infections

Total Reported Cases: Not reported
Hospital Onset: Not reported
Community Onset: Not reported
Related Deaths: Not reported

Available Reports

Annual Progress based on SIR: 0.63

State Reporting Laws

Data Submission Required: Yes
Data Publicly Available: No
Data Validated: Yes
Facility-specific Data Publicly Reported: No
LTC Facility Submission Required: Yes
LTC Facility Data Publicly Reported: No
Law/Regulation: Ark. Code Ann.

State Contact

Kelley Garner, MPH MLS(ASCP)CM
HAI Program Coordinator/ Epidemiologist
Arkansas Department of Health
Epidemiology Branch
4815 West Markham St., Slot 32
Little Rock, 72205
501-661-2296

CLINICAL TRIALS


OpTION

Official Title: CSP #596 – Optimal Treatment for Recurrent Clostridium Difficile Infection
Trial No. NCT02667418
Type: Interventional
Recruitment: Recruiting
Sponsor: VA Office of Research and Development
Contact: Michelle Johnson
(708) 202-8387 ext 27001
Gender: All
Age: 18 Years and older

RESTORATiVE303

Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
Gender: All
Age: 12 Years and older
Vedanta Biosciences has teamed up with Science37 to provide a site-less, decentralized approach. This means the study can be done remotely and the product comes to you, in your home. This allows applicants who are not near a study site or unable to travel to participate and receive treatment. You can sign up for the decentralized study here.